Business

Chemed To Report Second-Quarter 2025 Earnings July 29, 2025

CINCINNATI, June 27, 2025--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange.

articleChemed CorpJune 27, 20255/company/chemed-corp/news/chemed-report-second-quarter-2025-201500191
Chemed To Report Second-Quarter 2025 Earnings July 29, 2025

About this update from Chemed Corp

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2425,"height":791,"url":"https://media.zenfs.com/en/business-wire.com/1bd2ad997722a31883fb1c7a283c1ba9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Iick68E8NMQEeJgFs7xFEQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMxMztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/1bd2ad997722a31883fb1c7a283c1ba9","width":960,"height":313},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/I374Tq4sFs_30Vu4lJxqPg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03ODI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/1bd2ad997722a31883fb1c7a283c1ba9","width":1200,"height":391}},"lazy":false},{"type":"text","content":"Provides Current Update to 2025 Earnings Performance","length":52,"tagName":"p","attribs":{}},{"type":"text","content":"Related Conference Call to Be Held On July 30, 2025","length":51,"tagName":"p","attribs":{}},{"type":"text","content":"CINCINNATI, June 27, 2025--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange.","length":263,"tagName":"p"},{"type":"text","content":"Chemed also announced developments related to second quarter earnings and full year 2025 guidance.","length":98,"tagName":"p"},{"type":"text","content":"In prior public statements, management discussed the possibility that the VITAS subsidiary could have an aggregate Medicare Cap billing limitation (Medicare Cap) related to its Florida consolidated program, excluding Tallahassee. However, as of the most recent quarterly earnings update, VITAS internal projections showed that the Florida consolidated program would end the 2025 government fiscal year ending on September 30, 2025 (2025 Cap Year) with a Medicare Cap cushion. Actual Medicare admissions in both April and May 2025 in Florida were weaker than anticipated and lower than VITAS’ internal projections. As a result, VITAS now projects a Medicare Cap revenue limitation for the 2025 Cap Year of $18 million to $25 million related to the Florida consolidated program, excluding Tallahassee. The above projection includes actual results through May. Actual June results, which show better admissions than pr...

More updates from Chemed Corp

Chemed CorporationVITASFloridaNYSEinternal projections